Crosstalk between phosphorylation and multi-site arginine/lysine methylation in C/EBPs

Transcription

Volumn 2, Issue 1, 2011, Pages 3-8

  Leutz, Achim ^a,b   Pless, Ole ^a   Lappe, Michael ^c   Dittmar, Gunnar ^a   Kowenz Leutz, Elisabeth ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

Chromatin remodeling; Differentiation; Histone code; Methylation; Post translational modification; Signaling; Transcription

Indexed keywords

ARGININE; CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; LYSINE;

AMINO ACID SEQUENCE; ARTICLE; HUMAN; MUTATIONAL ANALYSIS; NONHUMAN; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 79952255809     PISSN: 21541264     EISSN: 21541272     Source Type: Journal    
DOI: 10.4161/trns.2.1.13510     Document Type: Article

References (48)

1. Johnson PF. Molecular stop signs: regulation of cell cycle arrest by C/EBP transcription factors. J Cell Sci 2005; 118:2545-55.
2. Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol 2007; 17:318-24.
3. Sebastian T, Johnson PF. Stop and go: anti-prolif- erative and mitogenic functions of the transcription factor C/EBPbeta. Cell Cycle 2006; 5:953-7.
4. Zahnow CA. CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases. Expert Rev Mol Med 2009; 11:12.
5. Calkhoven CF, Muller C, Leutz A. Translational control of gene expression and disease. Trends Mol Med 2002; 8:577-83.
6. Wethmar K, Smink JJ, Leutz A. Upstream open reading frames: molecular switches in (patho)physiology. Bioessays 2010; 32: 885-93. doi: 10.1002/ bies.201000037
7. Lee S, Shuman JD, Guszczynski T, Sakchaisri K, Sebastian T, Copeland TD, et al. RSK-mediated phosphorylation in the C/EBP{beta} leucine zipper regulates DNA binding, dimerization and growth arrest activity. Mol Cell Biol 2010; 30: 2621-35.
8. Nerlov C. C/EBPs: recipients of extracellular signals through proteome modulation. Curr Opin Cell Biol 2008; 20: 180-5.
9. Cesena TI, Cardinaux JR, Kwok R, Schwartz J. CCAAT/enhancer-binding protein (C/EBP)beta is acetylated at multiple lysines: acetylation of C/ EBPbeta at lysine 39 modulates its ability to activate transcription. J Biol Chem 2007; 282: 956-67.
10. Joo M, Park GY, Wright JG, Blackwell TS, Atchison ML, Christman JW. Transcriptional regulation of the cyclooxygenase-2 gene in macrophages by PU.1. J Biol Chem 2004; 279: 6658-65.
11. Xu M, Nie L, Kim SH, Sun XH. STAT5-induced Id-1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPbeta. EMBO J 2003; 22: 893-904.
12. Kowenz-Leutz E, Pless O, Dittmar G, Knoblich M, Leutz A. Crosstalk between C/EBPbeta phosphorylation, arginine methylation and SWI/SNF/Mediator implies an indexing transcription factor code. EMBO J 2010; 29: 1105-15.
13. Pless O, Kowenz-Leutz E, Knoblich M, Lausen J, Beyermann M, Walsh MJ, et al. G9a-mediated lysine methylation alters the function of CCAAT/ enhancer-binding protein-{beta}. J Biol Chem 2008; 283: 26357-63.
14. Kowenz-Leutz E, Twamley G, Ansieau S, Leutz A. Novel mechanism of C/EBPbeta (NF-M) transcriptional control: activation through derepression. Genes Dev 1994; 8: 2781-91.
15. Lee S, Miller M, Shuman JD, Johnson PF. CCAAT/ enhancer binding protein {beta} DNA binding is auto-inhibited by multiple elements that also mediate association with p300/CBP. J Biol Chem 2010; 285: 21399-410.
16. Williams SC, Baer M, Dillner AJ, Johnson PF. CRP2 (C/EBPbeta) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity. EMBO J 1995; 14: 3170-83.
17. Nerlov C, McNagny KM, Doderlein G, Kowenz-Leutz E, Graf T. Distinct C/EBP functions are required for eosinophil lineage commitment and maturation. Genes Dev 1998; 12: 2413-23.
18. Kowenz-Leutz E, Leutz A. A C/EBPbeta isoform recruits the SWI/SNF complex to activate myeloid genes. Mol Cell 1999; 4: 735-43.
19. Mo X, Kowenz-Leutz E, Xu H, Leutz A. Ras induces mediator complex exchange on C/EBPbeta. Mol Cell 2004; 13: 241-50.
20. Pedersen TA, Kowenz-Leutz E, Leutz A, Nerlov C. Cooperation between C/EBPalpha TBP/TFIIB and SWI/SNF recruiting domains is required for adipocyte differentiation. Genes Dev 2001; 15: 3208-16.
21. Muller C, Calkhoven CF, Sha X, Leutz A. The CCAAT enhancer-binding protein alpha (C/ EBPalpha) requires a SWI/SNF complex for proliferation arrest. J Biol Chem 2004; 279: 7353-8.
22. Berberich-Siebelt F, Berberich I, Andrulis M, Santner-Nanan B, Jha MK, Klein-Hessling S, et al. SUMOylation interferes with CCAAT/enhancer-binding protein beta-mediated c-myc repression, but not IL-4 activation in T cells. J Immunol 2006; 176: 4843-51.
23. Eaton EM, Sealy L. Modification of CCAAT/ enhancer-binding protein-beta by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3. J Biol Chem 2003; 278: 33416-21.
24. Kim J, Cantwell CA, Johnson PF, Pfarr CM, Williams SC. Transcriptional activity of CCAAT/enhancer-binding proteins is controlled by a conserved inhibitory domain that is a target for sumoylation. J Biol Chem 2002; 277: 38037-44.
25. Subramanian L, Benson MD, Iniguez-Lluhi JA. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3. J Biol Chem 2003; 278: 9134-41.
26. Nakajima T, Kinoshita S, Sasagawa T, Sasaki K, Naruto M, Kishimoto T, et al. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci USA 1993; 90: 2207-11.
27. Eastburn D, Han M. When Ras signaling reaches the mediator. Dev Cell 2004; 6: 158-9.
28. Dyson HJ, Wright PE. Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol 2005; 6: 197-208.
29. Linding R, Russell RB, Neduva V, Gibson TJ. GlobPlot: Exploring protein sequences for globularity and disorder. Nucleic Acids Res 2003; 31: 3701-8.
30. Liu J, Perumal NB, Oldfield CJ, Su EW, Uversky VN, Dunker AK. Intrinsic disorder in transcription factors. Biochemistry 2006; 45: 6873-88.
31. Tompa P. Intrinsically unstructured proteins evolve by repeat expansion. Bioessays 2003; 25: 847-55.
32. Mink S, Haenig B, Klempnauer KH. Interaction and functional collaboration of p300 and C/EBPbeta. Mol Cell Biol 1997; 17: 6609-17.
33. Nerlov C, Ziff EB. CCAAT/enhancer binding protein-alpha amino acid motifs with dual TBP and TFIIB binding ability co-operate to activate transcription in both yeast and mammalian cells. EMBO J 1995; 14: 4318-28.
34. Dunker AK, Lawson JD, Brown CJ, Williams RM, Romero P, Oh JS, et al. Intrinsically disordered protein. J Mol Graph Model 2001; 19: 26-59.
35. Uversky VN. Natively unfolded proteins: a point where biology waits for physics. Protein Sci 2002; 11: 739-56.
36. Mo X, Kowenz-Leutz E, Laumonnier Y, Xu H, Leutz A. Histone H3 tail positioning and acetylation by the c-Myb but not the v-Myb DNA-binding SANT domain. Genes Dev 2005; 19: 2447-57.
37. Chen SS, Chen JF, Johnson PF, Muppala V, Lee YH. C/EBPbeta, when expressed from the C/ebpalpha gene locus, can functionally replace C/EBPalpha in liver but not in adipose tissue. Mol Cell Biol 2000; 20: 7292-9.
38. Chiu CH, Lin WD, Huang SY, Lee YH. Effect of a C/EBP gene replacement on mitochondrial biogenesis in fat cells. Genes Dev 2004; 18: 1970-5.
39. Higashimoto K, Kuhn P, Desai D, Cheng X, Xu W. Phosphorylation-mediated inactivation of coactivator-associated arginine methyltransferase 1. Proc Natl Acad Sci USA 2007; 104: 12318-23.
40. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature 2010; 463: 318-25.
41. Gomis RR, Alarcon C, Nadal C, Van Poznak C, Massague J. C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 2006; 10: 203-14.
42. Benayoun BA, Veitia RA. A post-translational modification code for transcription factors: sorting through a sea of signals. Trends Cell Biol 2009; 19: 189-97.
43. Sims RJ, 3rd, Reinberg D. Is there a code embedded in proteins that is based on post-translational modifications? Nat Rev Mol Cell Biol 2008; 9: 815-20.
44. Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ. How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat Struct Mol Biol 2007; 14: 1025-40.
45. Kajimura S, Seale P, Kubota K, Lunsford E, Frangioni JV, Gygi SP, et al. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex. Nature 2009; 460: 1154-8.
46. Murray-Zmijewski F, Slee EA, Lu X. A complex barcode underlies the heterogeneous response of p53 to stress. Nat Rev Mol Cell Biol 2008; 9: 702-12.
47. Chi P, Allis CD, Wang GG. Covalent histone modifications-miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 2010; 10: 457-69.
48. Yang XJ. Multisite protein modification and intramolecular signaling. Oncogene 2005; 24: 1653-62.